Jeffrey Jundt
Rheumatology · Killeen, TXNPI 1548364649
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.6% of the total across 200 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 24.9% of the total. Reporting peaked in 2021 at $1,332 and has fallen 68.0% since, to $426 in 2022. That places this record below the midpoint for rheumatology clinicians in TX, where the typical reported total is $3,779.
Across 200 payments — averaging $19.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$984
- Amgen$850
- Johnson & Johnson$611
- UCB, Inc.$324
- Lilly USA, LLC$192
- Novartis$152
- plus $847 from 13 others
Across 3 payments — averaging $1374.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$4K
What the payments were for
- Grants$2406%
- Food & beverage$3,70794%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $984 |
| Amgen(2 entities) | 45 | $850 |
| Johnson & Johnson(2 entities) | 34 | $611 |
| UCB, Inc. | 15 | $324 |
| Lilly USA, LLC | 10 | $192 |
| Novartis | 5 | $152 |
| Bristol Myers Squibb | 7 | $144 |
| GSK | 7 | $128 |
| Pfizer | 7 | $121 |
| AstraZeneca(2 entities) | 5 | $81 |
| Sanofi | 1 | $80 |
| Genentech USA, Inc. | 5 | $77 |
| E.r. Squibb & Sons, L.L.C. | 4 | $71 |
| Boehringer Ingelheim | 2 | $53 |
| Abbott | 1 | $34 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Merck | 1 | $15 |
| Bioventus LLC | 1 | $15 |
| Pacira Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,960 in reported general payments places this provider in the 50th percentile of 512 rheumatology providers in Texas.
Other rheumatology in Killeen
- John CushDallas$3.7M
- Sanjay ChabraEl Paso$3.3M
- Dhiman BasuColleyville$1.8M
- Frank WellborneNew Braunfels$1.4M
- Christopher ParkerWest Lake Hills$1.4M
- Pendleton WickershamSan Antonio$954K
- Henry TownsendPlano$738K
- Zoran KurepaDallas$483K
- Giovanni GeslaniDallas$415K
- Dianne PetroneDallas$401K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.